Form 4 for BMEA Biomea Fusion, Inc.
Accepted 2022-08-19 00:00:00 ET · period of report 2022-08-16 · accession 0001859061-22-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-08-19 | 2022-08-16 | BMEA | A2A Pharmaceuticals, Inc. | 10% | P - Purchase | $13.87 | -30.7K | 4.30M | -0.7% | -$425.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-08-16 | P | D | 30,684 | $13.87 | 4,300,000 | D | — | — | (F1) Shares were sold in multiple transaction in a range of prices from 13.65 to 14.01 and an average price of 13.872. Details of the specific trades are available upon request |